With more than 25 years’ experience manufacturing viral vectors for pre-clinical studies to commercialization and highly qualified experts invested in the process development, scale-up, tech transfer, and manufacturing of viral vectors we are the best strategic partner for you. We have process development/tech transfer/manufacturing teams with proven history of successful tech transfer and continuous process improvement. Our proven scalable platforms can overcome production challenges with Lentivirus and Adeno-Associated Virus (AAV). Our Project Management team is dedicated to keeping both manufacturing and development projects on time and our Product Development Process (PDP) ensures development of a risk-based and scalable processes designed to build solid foundation for commercialization. We have established synergy between production and testing within one company supporting early development through commercial production, proven FDA/EMA compliant quality systems for commercial release of approved products, and a history of successfully navigating the commercial regulatory pathways.